Related Experiment Video
Updated: Jul 23, 2025

Oct4GiP Reporter Assay to Study Genes that Regulate Mouse Embryonic Stem Cell Maintenance and Self-renewal
Published on: May 30, 2012
Polycomb repressive complex 2 binds and stabilizes NANOG to suppress differentiation-related genes to promote
Da-Wei Yeh1, Cheng Liu1, Juan Carlos Hernandez1
1Departments of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA 90033, USA.
Abstract:
The synergistic effect of alcohol and HCV mediated through TLR4 signaling transactivates NANOG, a pluripotency transcription factor important for the stemness of tumor-initiating stem-like cells (TICs). NANOG together with the PRC2 complex suppresses expression of oxidative phosphorylation (OXPHOS) genes to generate TICs. The phosphodegron sequence PEST domain of NANOG binds EED to stabilize NANOG protein by blocking E3 ligase recruitment and proteasome-dependent degradation, while the tryptophan-rich domain of NANOG binds EZH2 and SUZ12. Human ARID1A gene loss results in the resistance to combined FAO and PRC2 inhibition therapies due to reduction of mitochondrial ROS levels. CRISPR-Cas9-mediated ARID1A knockout and/or constitutively active CTNNB1 driver mutations promoted tumor development in humanized FRG HCC mouse models, in which use of an interface inhibitor antagonizing PRC2-NANOG binding and/or FAO inhibitor blocked tumor growth. Together, the PRC2-NANOG interaction becomes a new drug target for HCC via inducing differentiation-related genes, destabilizing NANOG protein, and suppressing NANOG activity.
Insights
Alcohol and Hepatitis C Virus (HCV) co-infection promote liver cancer stemness by activating NANOG. Targeting the PRC2-NANOG interaction offers a new therapeutic strategy for hepatocellular carcinoma (HCC).
Area of Science:
- Hepatocellular Carcinoma (HCC) Pathogenesis
- Cancer Stem Cell Biology
- Molecular Oncology
Background:
- Alcohol and Hepatitis C Virus (HCV) synergistically promote hepatocellular carcinoma (HCC) through Toll-like receptor 4 (TLR4) signaling.
- NANOG, a pluripotency transcription factor, is crucial for maintaining the stemness of tumor-initiating cells (TICs) in HCC.
- NANOG, in complex with PRC2, suppresses oxidative phosphorylation (OXPHOS) gene expression, thereby generating TICs.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying alcohol and HCV-mediated HCC development.
- To investigate the role of NANOG and its interaction with the PRC2 complex in TIC generation.
- To identify novel therapeutic targets for HCC treatment.
Main Methods:
- Investigated the synergistic effects of alcohol and HCV on TLR4 signaling and NANOG activation.
- Analyzed the interaction between NANOG, PRC2 complex (EED, EZH2, SUZ12), and the PEST domain.
- Utilized CRISPR-Cas9-mediated ARID1A knockout and CTNNB1 mutations in humanized FRG HCC mouse models.
- Assessed the efficacy of PRC2-NANOG interface inhibitors and FAO inhibitors in blocking tumor growth.
Main Results:
- Alcohol and HCV synergistically activate NANOG via TLR4 signaling, promoting HCC stemness.
- NANOG protein stability is regulated by its PEST domain binding to EED, preventing proteasomal degradation.
- Human ARID1A loss confers resistance to FAO and PRC2 inhibition by reducing mitochondrial ROS.
- CRISPR-Cas9-mediated ARID1A knockout and CTNNB1 mutations promote HCC development.
- Inhibiting the PRC2-NANOG interaction or FAO effectively blocks tumor growth in mouse models.
Conclusions:
- The PRC2-NANOG interaction is a critical driver of HCC stemness and tumor development.
- Targeting the PRC2-NANOG interaction represents a promising therapeutic strategy for HCC.
- Inducing differentiation-related genes and destabilizing NANOG protein can suppress HCC progression.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Maintenance of the ES Cell State
Abnormal Proliferation
Negative Regulator Molecules
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

